Metagenomi Therapeutics, Inc. MGX Q1 2025 earnings
Reported May 13, 2025 · Before market open
Revenue$4.1MMiss by $4.2M
EPS-$0.68Miss by $0.06
Revenue estimate$8.3M
EPS estimate-$0.62
Next report
Aug 11, 2026 (In 1 week)Revenue estimate$3.0M
EPS estimate-$0.55
Versus estimates
Revenue
Diluted EPS
Ask the moment Metagenomi Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Metagenomi Therapeutics, Inc. report Q1 2025 earnings?
- Metagenomi Therapeutics, Inc. (MGX) reported Q1 2025 earnings on May 13, 2025 before market open.
- What were Metagenomi Therapeutics, Inc. 's Q1 2025 revenue and EPS?
- Metagenomi Therapeutics, Inc. reported revenue of $4.1M and eps of $-0.68 for Q1 2025.
- Did Metagenomi Therapeutics, Inc. beat estimates in Q1 2025?
- Revenue missed the consensus estimate of $8.3M by $4.2M. EPS missed the consensus estimate of $-0.62 by $0.06.
- How did Metagenomi Therapeutics, Inc. 's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 63.0% from $11.2M a year earlier and eps grew 42.9% from $-1.19.
- Where can I find Metagenomi Therapeutics, Inc. 's Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-070463) directly on SEC EDGAR. The filing index links above go to sec.gov.